Lipoteichoic Acid Partially Contributes to the Inflammatory Responses to Enterococcus faecalis

Journal of Endodontics

Volumn 34, Issue 8, 2008, Pages 975-982

  Baik, Jung Eun ^a   Ryu, Young Hee ^a   Han, Ji Young ^a   Im, Jintaek ^a   Kum, Kee Yeon ^a   Yun, Cheol Heui ^b   Lee, Kangseok ^c   Han, Seung Hyun ^a,d  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Chung Ang University   (South Korea)

^d International Vaccine Institute   (South Korea)

Author keywords

Apical periodontitis; Enterococcus faecalis; innate immunity; lipoteichoic acid; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; NITRIC OXIDE; TEICHOIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECT; ENTEROCOCCUS FAECALIS; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOGENICITY; TOOTH PERIAPICAL DISEASE;

ANIMALS; CELL LINE; ENTEROCOCCUS FAECALIS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE; PERIAPICAL PERIODONTITIS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE FACTORS;

EID: 47249148760     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2008.05.005     Document Type: Article

References (35)

1. Wisplinghoff H., Seifert H., Tallent S.M., Bischoff T., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 22 (2003) 686-691
2. Flahaut S., Hartke A., Giard J.C., and Auffray Y. Alkaline stress response in Enterococcus faecalis: adaptation, cross-protection, and changes in protein synthesis. Appl Environ Microbiol 63 (1997) 812-814
3. Hunt C.P. The emergence of enterococci as a cause of nosocomial infection. Br J Biomed Sci 55 (1998) 149-156
4. Gordon S., Swenson J.M., Hill B.C., et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol 30 (1992) 2373-2378
5. Hancock III H.H., Sigurdsson A., Trope M., and Moiseiwitsch J. Bacteria isolated after unsuccessful endodontic treatment in a North American population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 579-586
6. Stuart C.H., Schwartz S.A., Beeson T.J., and Owatz C.B. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod 32 (2006) 93-98
7. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2 (2002) 171-179
8. Fabretti F., Theilacker C., Baldassarri L., et al. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun 74 (2006) 4164-4171
9. Theilacker C., Kaczynski Z., Kropec A., et al. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect Immun 74 (2006) 5703-5712
10. Hermann C., Spreitzer I., Schroder N.W., et al. Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 32 (2002) 541-551
11. Morath S., Geyer A., and Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193 (2001) 393-397
12. Morath S., Geyer A., Spreitzer I., Hermann C., and Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations. Infect Immun 70 (2002) 938-944
13. Gao J.J., Xue Q., Zuvanich E.G., Haghi K.R., and Morrison D.C. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect Immun 69 (2001) 751-757
14. Han S.H., Kim J.H., Martin M., Michalek S.M., and Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 71 (2003) 5541-5548
15. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
16. Medvedev A.E., Henneke P., Schromm A., et al. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J Immunol 167 (2001) 2257-2267
17. Han S.H., Jeon Y.J., Yea S.S., and Yang K.H. Suppression of the interleukin-2 gene expression by aflatoxin B1 is mediated through the down-regulation of the NF-AT and AP-1 transcription factors. Toxicol Lett 108 (1999) 1-10
18. Seo H.S., Michalek S.M., and Nahm M.H. Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect Immun 76 (2008) 206-213
19. Schroder N.W., Morath S., Alexander C., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278 (2003) 15587-15594
20. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
21. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 (1999) 1-5
22. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274 (1999) 17406-17409
23. Medzhitov R., and Janeway Jr. C.A. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9 (1997) 4-9
24. Grandel U., Hopf M., Buerke M., et al. Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts. Circulation 112 (2005) 691-698
25. Kengatharan K.M., De Kimpe S., Robson C., Foster S.J., and Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 188 (1998) 305-315
26. Morath S., Stadelmaier A., Geyer A., Schmidt R.R., and Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 195 (2002) 1635-1640
27. Korhonen R., Korpela R., Saxelin M., Maki M., Kankaanranta H., and Moilanen E. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation 25 (2001) 223-232
28. Deininger S., Stadelmaier A., von Aulock S., Morath S., Schmidt R.R., and Hartung T. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J Immunol 170 (2003) 4134-4138
29. Knuefermann P., Sakata Y., Baker J.S., et al. Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 110 (2004) 3693-3698
30. Malley R., Henneke P., Morse S.C., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100 (2003) 1966-1971
31. Mutoh N., Tani-Ishii N., Tsukinoki K., Chieda K., and Watanabe K. Expression of toll-like receptor 2 and 4 in dental pulp. J Endod 33 (2007) 1183-1186
32. Zoletti G.O., Siqueira Jr. J.F., and Santos K.R. Identification of Enterococcus faecalis in root-filled teeth with or without periradicular lesions by culture-dependent and-independent approaches. J Endod 32 (2006) 722-726
33. Orstavik D., and Haapasalo M. Disinfection by endodontic irrigants and dressings of experimentally infected dentinal tubules. Endod Dent Traumatol 6 (1990) 142-149
34. Sobrinho A.P., Barros M.H., Nicoli J.R., et al. Experimental root canal infections in conventional and germ-free mice. J Endod 24 (1998) 405-408
35. Evans M., Davies J.K., Sundqvist G., and Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endod J 35 (2002) 221-228